Gorog D. et al. [32] reported that circulating soluble CD40L levels were significantly increased in patients with COVID-19 compared to healthy controls, suggesting a relationship with our results regarding the presence of persistent COVID symptoms and inflammatory disease progression. Here, CD40LG is linked to COVID-19.